arrow
Chan Wai-yee 封面图

Chan Wai-yee (Wai-Yee Chan)

chinese university of hongkongLi Ka Shing Professor of Biomedical Sciences
H指数:62
被引数:1.5万

个人简介

Obtained a BSc (Hon. 1st Class) in Chemistry from The Chinese University of Hong Kong in 1974 and a PhD in Biochemistry from the University of Florida, Gainesville, Florida, USA in 1977. He served as tenured Assistant to Associate Professor at the Department of Pediatrics, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA from 1979 to 1989, and tenured Professor in the Department of Pediatrics and Department of Biochemistry, Cell & Molecular Biology at Georgetown University Medical Center, Washington, DC, USA from 1989 to 2009. In 2001, he was jointly appointed at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), USA, and later served as Head and Principal Investigator of the Section on Developmental Genomics. In 2009, he established the School of Biomedical Sciences, Faculty of Medicine, CUHK, serving as the Founding Director and Chair Professor of Biomedical Sciences. He served as Master of CW Chu College from 2017 to 2021 and was appointed Pro-Vice-Chancellor (Strategic Developments)/ Vice President of CUHK in 2018 and Li Ka Shing Professor of Biomedical Sciences in 2020. He is the Director of the Institute for Tissue Engineering and Regenerative Medicine (iTERM). Notable honors include the Merrick Award for Outstanding Biomedical Research and the Presidential Award from the Association of Chinese Geneticists in America.

教育背景

  • 1974.12

    The Chinese University of Hong Kong BSc (Hon. 1st Class) Chemistry

  • 1977.12

    University of Florida, Gainesville, Florida, USA PhD Biochemistry

工作经历

  • 2020.01 – 至今

    CUHK

    Li Ka Shing Professor of Biomedical Sciences

  • 2018.01 – 至今

    CUHK

    Pro-Vice-Chancellor (Strategic Developments)/ Vice President

  • 2017.01 – 2021.12

    CW Chu College

    Master

  • 2009.01 – 至今

    School of Biomedical Sciences, Faculty of Medicine, CUHK

    Founding Director and Chair Professor of Biomedical Sciences

  • 2001.01 – 至今

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), USA

    Head and Principal Investigator of the Section on Developmental Genomics

  • 1989.01 – 2009.12

    Georgetown University Medical Center, Washington, DC, USA

    Professor, Department of Pediatrics and Department of Biochemistry, Cell & Molecular Biology

  • 1979.01 – 1989.12

    University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA

荣誉奖项

  1. Merrick Award for Outstanding Biomedical Research
  2. Presidential Award|Association of Chinese Geneticists in America, USA
  3. 2025 Year-end Excellent Paper Award(2025)
Microprotein PLUM encoded by Lin28b uORF is a cytoplasmic determinant of pluripotency and embryonic development

由Lin28b uORF编码的微蛋白PLUM是多能性和胚胎发育的细胞质决定因子。

2025-11-260
OAAI
The mitochondrial unfolded protein response inhibits pluripotency acquisition and mesenchymal-to-epithelial transition in somatic cell reprogramming

线粒体未折叠蛋白反应抑制体细胞重编程中的多能性获得和间充质-上皮转化

2025-04-091
PRE
Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia

Bruton酪氨酸激酶抑制剂治疗华氏巨球蛋白血症的ASPEN研究第3期中周围神经病变

2025-02-122
OA
Long-Term Impact of Dose Interruptions (DIs) of Bruton Tyrosine Kinase Inhibitors (BTKis) on Change in IgM Levels and Clinical Outcomes in Waldenström Macroglobulinemia (WM)

布鲁顿酪氨酸激酶抑制剂(BTKis)剂量中断(DIs)对华氏巨球蛋白血症(WM)患者IgM水平变化及临床结局的长期影响

BLOOD
IF23.1
2024-11-050
PRE
A novel protein CYTB-187AA encoded by the mitochondrial gene CYTB modulates mammalian early development
2024-07-016
PRE
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
2024-03-283
OAAI